Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 11070-73-8
2. Insulin(cattle)
Molecular Weight | 5734 g/mol |
---|---|
Molecular Formula | C254H377N65O75S6 |
XLogP3 | -12.8 |
Hydrogen Bond Donor Count | 76 |
Hydrogen Bond Acceptor Count | 87 |
Rotatable Bond Count | 176 |
Exact Mass | 5731.6075805 g/mol |
Monoisotopic Mass | 5729.6008708 g/mol |
Topological Polar Surface Area | 2410 Ų |
Heavy Atom Count | 400 |
Formal Charge | 0 |
Complexity | 14400 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 49 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Related Excipient Companies
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Insulin (bovine) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Insulin (bovine), including repackagers and relabelers. The FDA regulates Insulin (bovine) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Insulin (bovine) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Insulin (bovine) supplier is an individual or a company that provides Insulin (bovine) active pharmaceutical ingredient (API) or Insulin (bovine) finished formulations upon request. The Insulin (bovine) suppliers may include Insulin (bovine) API manufacturers, exporters, distributors and traders.
click here to find a list of Insulin (bovine) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Insulin (bovine) DMF (Drug Master File) is a document detailing the whole manufacturing process of Insulin (bovine) active pharmaceutical ingredient (API) in detail. Different forms of Insulin (bovine) DMFs exist exist since differing nations have different regulations, such as Insulin (bovine) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Insulin (bovine) DMF submitted to regulatory agencies in the US is known as a USDMF. Insulin (bovine) USDMF includes data on Insulin (bovine)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Insulin (bovine) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Insulin (bovine) suppliers with USDMF on PharmaCompass.
A Insulin (bovine) CEP of the European Pharmacopoeia monograph is often referred to as a Insulin (bovine) Certificate of Suitability (COS). The purpose of a Insulin (bovine) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Insulin (bovine) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Insulin (bovine) to their clients by showing that a Insulin (bovine) CEP has been issued for it. The manufacturer submits a Insulin (bovine) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Insulin (bovine) CEP holder for the record. Additionally, the data presented in the Insulin (bovine) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Insulin (bovine) DMF.
A Insulin (bovine) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Insulin (bovine) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Insulin (bovine) suppliers with CEP (COS) on PharmaCompass.
Insulin (bovine) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Insulin (bovine) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Insulin (bovine) GMP manufacturer or Insulin (bovine) GMP API supplier for your needs.
A Insulin (bovine) CoA (Certificate of Analysis) is a formal document that attests to Insulin (bovine)'s compliance with Insulin (bovine) specifications and serves as a tool for batch-level quality control.
Insulin (bovine) CoA mostly includes findings from lab analyses of a specific batch. For each Insulin (bovine) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Insulin (bovine) may be tested according to a variety of international standards, such as European Pharmacopoeia (Insulin (bovine) EP), Insulin (bovine) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Insulin (bovine) USP).
LOOKING FOR A SUPPLIER?